Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by "antioxidant" metal chelators: From ferroptosis to stroke
- PMID: 23376032
- PMCID: PMC4327984
- DOI: 10.1016/j.freeradbiomed.2013.01.026
Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by "antioxidant" metal chelators: From ferroptosis to stroke
Abstract
Neurologic conditions including stroke, Alzheimer disease, Parkinson disease, and Huntington disease are leading causes of death and long-term disability in the United States, and efforts to develop novel therapeutics for these conditions have historically had poor success in translating from bench to bedside. Hypoxia-inducible factor (HIF)-1α mediates a broad, evolutionarily conserved, endogenous adaptive program to hypoxia, and manipulation of components of the HIF pathway is neuroprotective in a number of human neurological diseases and experimental models. In this review, we discuss molecular components of one aspect of hypoxic adaptation in detail and provide perspective on which targets within this pathway seem to be ripest for preventing and repairing neurodegeneration. Further, we highlight the role of HIF prolyl hydroxylases as emerging targets for the salutary effects of metal chelators on ferroptosis in vitro as well in animal models of neurological diseases.
Keywords: Free radicals; Hypoxia-inducible factors; Metal chelators; Neurodegeneration; Prolyl hydroxylases; Transcription.
Copyright © 2013 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures

Similar articles
-
Hypoxia-inducible factor prolyl hydroxylase inhibition: robust new target or another big bust for stroke therapeutics?J Cereb Blood Flow Metab. 2012 Jul;32(7):1347-61. doi: 10.1038/jcbfm.2012.28. Epub 2012 Mar 14. J Cereb Blood Flow Metab. 2012. PMID: 22415525 Free PMC article. Review.
-
Neuroprotective multifunctional iron chelators: from redox-sensitive process to novel therapeutic opportunities.Antioxid Redox Signal. 2010 Sep 15;13(6):919-49. doi: 10.1089/ars.2009.2929. Antioxid Redox Signal. 2010. PMID: 20095867 Review.
-
Harnessing hypoxic adaptation to prevent, treat, and repair stroke.J Mol Med (Berl). 2007 Dec;85(12):1331-8. doi: 10.1007/s00109-007-0283-1. Epub 2007 Nov 28. J Mol Med (Berl). 2007. PMID: 18043901 Free PMC article. Review.
-
Hypoxia-inducible factor-1 as targets for neuroprotection : from ferroptosis to Parkinson's disease.Neurol Sci. 2025 Mar;46(3):1111-1120. doi: 10.1007/s10072-024-07832-x. Epub 2024 Oct 28. Neurol Sci. 2025. PMID: 39466326 Review.
-
Prolyl hydroxylase domain inhibitors: a route to HIF activation and neuroprotection.Antioxid Redox Signal. 2010 Apr;12(4):459-80. doi: 10.1089/ars.2009.2870. Antioxid Redox Signal. 2010. PMID: 19737089 Review.
Cited by
-
Ferroptosis in Acute Central Nervous System Injuries: The Future Direction?Front Cell Dev Biol. 2020 Jul 15;8:594. doi: 10.3389/fcell.2020.00594. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32760721 Free PMC article.
-
Mechanistic Insights of Chelator Complexes with Essential Transition Metals: Antioxidant/Pro-Oxidant Activity and Applications in Medicine.Int J Mol Sci. 2022 Jan 23;23(3):1247. doi: 10.3390/ijms23031247. Int J Mol Sci. 2022. PMID: 35163169 Free PMC article. Review.
-
Genome maintenance and bioenergetics of the long-lived hypoxia-tolerant and cancer-resistant blind mole rat, Spalax: a cross-species analysis of brain transcriptome.Sci Rep. 2016 Dec 9;6:38624. doi: 10.1038/srep38624. Sci Rep. 2016. PMID: 27934892 Free PMC article.
-
Tetramethylpyrazine inhibits ferroptosis in spinal cord injury by regulating iron metabolism through the NRF2/ARE pathway.Front Pharmacol. 2024 Nov 15;15:1503064. doi: 10.3389/fphar.2024.1503064. eCollection 2024. Front Pharmacol. 2024. PMID: 39619616 Free PMC article.
-
Ferroptosis and Its Role in Diverse Brain Diseases.Mol Neurobiol. 2019 Jul;56(7):4880-4893. doi: 10.1007/s12035-018-1403-3. Epub 2018 Nov 8. Mol Neurobiol. 2019. PMID: 30406908 Free PMC article. Review.
References
-
- Ryu H, Lee J, Olofsson BA, Mwidau A, Dedeoglu A, Escudero M, Flemington E, Azizkhan-Clifford J, Ferrante RJ, Ratan RR. Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway. Proc Natl Acad Sci U S A. 2003;100:4281–4286. - PMC - PubMed
-
- Siddiq A, Ayoub IA, Chavez JC, Aminova L, Shah S, LaManna JC, Patton SM, Connor JR, Cherny RA, Volitakis I, Bush AI, Langsetmo I, Seeley T, Gunzler V, Ratan RR. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system. J Biol Chem. 2005;280:41732–41743. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical